AC Immune

ACIUNasdaq Switzerland Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$240.186 M

$2.36 +1.72%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

101,742,231

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#254Emergent BioSolutionsEBS$249.7M
#255Sol-Gel TechnologiesSLGL$247.3M
#256AC ImmuneACIU$240.2M
#257OrganogenesisORGO$239.3M
#258Capricor TherapeuticsCAPR$236.9M

Where these numbers come from

Share counts and financials for AC Immune are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.